Access Granted:

Design and execute a cohort screening plan for your next study
Using the world’s largest commercial repository of FFPE tissue coupled with expert histopathology, IHC, and genomic services.

UNDERSTAND

Testing Strategies

Learn More

  • Define the end goal: samples characterized for your biomarker of interest
  • Utilize Discovery’s expertise to define appropriate testing methods
  • Benefit from the experience of our expert scientists
  • Leverage extensive IHC, PCR and genomic assay options
  • Develop a strategy for a cohort of low prevalence markers

ACCESS

The World’s Largest Commercial FFPE Biorepository

Learn More

  • Access Discovery’s unrivaled FFPE biorepository to supply the maximum N for your study
  • Perform high-throughput screening of your cohort
  • Analyze results using our team of experts

UTILIZE

Characterized FFPE

Learn More

  • Review the results and identify the samples of interest: known positives, negatives, and/or varying levels of expression
  • Receive the full FFPE block from every case selected along with:
    • Screening data
    • Scoring/interpretation
    • Aperio scans (if applicable)
    • Complete de-identified original pathology reports
Example CohortsTest and Modality
MSI Colon, Endo, GastricMMR (IHC), MSI (PCR)
HPV H&N, Cervicalp16 (IHC), HPV Subtyping (PCR)
Lung Adeno CohortPD-L1, CD8 (IHC), Illumina TST170 (NGS)
NSCLC Rare FusionsALK, MET, RET, ROS1, NTRK (ISH, NGS)
Driver MutationsEGFR, KRAS, BRAF V600E (IHC, PCR, NGS)
Integrated with our expert ihc services,
Discovery also has the world’s largest commercial biorepository of FFPE tissues and provides flow cytometry and sequencing services to fully understand target expression and comprehensively validate robust IHC assays.
IHC Services
Learn More
FFPE Tissue
Learn More
Flow Cytometry
Learn More

Connect With Us

Submit this form to start a conversation with Discovery to:
1

Begin IHC Service Project
2

Explore FFPE Inventory for IHC Analysis
3

Ask questions about our tissue biomarker solutions